Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDExagen Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.37 | -$0.35 | -$0.36 |
| Q2 2024 | 1 | -$0.35 | -$0.33 | -$0.34 |
| Q3 2024 | 1 | -$0.30 | -$0.28 | -$0.29 |
| Q4 2024 | 2 | -$0.27 | -$0.26 | -$0.26 |
| Q1 2025 | 2 | -$0.24 | -$0.23 | -$0.23 |
| Q2 2025 | 1 | -$0.17 | -$0.16 | -$0.17 |
| Q3 2025 | 1 | -$0.16 | -$0.15 | -$0.16 |
| Q4 2025 | 1 | -$0.11 | -$0.10 | -$0.11 |
| Q1 2026 | 1 | -$0.14 | -$0.13 | -$0.14 |
| Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2026 | 1 | -$0.11 | -$0.10 | -$0.11 |
| Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
Exagen Inc. Earnings Date And Information
Exagen Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.28 earnings per share for the quarter, topping analysts' consensus estimates of $-0.3 by $0.02. The company had revenue of 12.51 M for the quarter and had revenue of 52.55 M for the year. Exagen Inc. has generated $-1 earnings per share over the last year ($-1.34 diluted earnings per share) and currently has a price-to-earnings ratio of -5.78. Exagen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Exagen Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.30 | -$0.28 | 0.02 | $13.57 M | $12.51 M |
| 08/05/2024 | Q2 2024 | -$0.36 | -$0.16 | 0.2 | $13.13 M | $15.06 M |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.19 | 0.21 | $14.42 M | |
| 03/18/2024 | Q4 2023 | -$0.41 | -$0.31 | 0.1 | $13.77 M | |
| 11/13/2023 | Q3 2023 | -$0.50 | -$0.31 | 0.19 | $10.33 M | $13.42 M |
| 08/07/2023 | Q2 2023 | -$0.48 | -$0.28 | 0.2 | $10.93 M | $14.14 M |
| 05/15/2023 | Q1 2023 | -$0.52 | -$0.47 | 0.05 | $11.23 M | |
| 03/20/2023 | Q4 2022 | -$0.71 | -$0.83 | -0.12 | $12.84 M | |
| 11/21/2022 | Q3 2022 | -$0.14 | $9.05 M | $14.73 M | ||
| 08/04/2022 | Q2 2022 | -$0.55 | -$0.82 | -0.27 | $12.03 M | $8.96 M |
| 05/11/2022 | Q1 2022 | -$0.59 | -$0.64 | -0.05 | $10.39 M | |
| 03/22/2022 | Q4 2021 | -$0.49 | -$0.42 | 0.07 | $12.69 M | |
| 11/10/2021 | Q3 2021 | -$0.43 | -$0.42 | 0.01 | $12.13 M | $12.25 M |
| 08/09/2021 | Q2 2021 | -$0.50 | -$0.38 | 0.12 | $11.48 M | $12.77 M |
| 05/11/2021 | Q1 2021 | -$0.46 | -$0.48 | -0.02 | $10.59 M | |
| 03/16/2021 | Q4 2020 | -$0.33 | -$0.27 | 0.06 | $12.67 M | |
| 11/10/2020 | Q3 2020 | -$0.48 | -$0.34 | 0.14 | $8.73 M | $10.78 M |
| 07/28/2020 | Q2 2020 | -$0.77 | -$0.27 | 0.5 | $4.67 M | $8.95 M |
| 05/11/2020 | Q1 2020 | -$0.63 | -$0.44 | 0.19 | $9.58 M | |
| 03/25/2020 | Q4 2019 | -$0.40 | -$0.27 | 0.13 | $10.21 M |
Exagen Inc. Earnings: FAQ's
When is Exagen Inc.'s earnings date?
Exagen Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
Did Exagen Inc. beat their earnings estimates last
quarter?
In the previous quarter, Exagen Inc. (:XGN) reported $-0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.3 by $0.02.
How can I listen to Exagen Inc.'s earnings conference
call?
The conference call for Exagen Inc.'s latest earnings report can be listened to online.
How can I read Exagen Inc.'s conference call transcript?
The conference call transcript for Exagen Inc.'s latest earnings report can be read online.
How much revenue does Exagen Inc. generate each year?
Exagen Inc. (:XGN) has a recorded annual revenue of $52.55 M.
How much profit does Exagen Inc. generate each year?
Exagen Inc. (:XGN) has a recorded net income of $52.55 M. Exagen Inc. has generated $-1.34 earnings per share over the last four quarters.
What is Exagen Inc.'s price-to-earnings ratio?
Exagen Inc. (:XGN) has a price-to-earnings ratio of -5.78 and price/earnings-to-growth ratio is -1.87.